Rehabilitation program for adults with Guillain-Barré syndrome
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial studies whether an inpatient rehabilitation program can help people with Guillain-Barré syndrome. It may be useful if you need structured therapy and support during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with Guillain-Barré syndrome
- You are willing to stay in a hospital inpatient rehabilitation program
- You can agree to participate (provide informed consent)
- You do not have major heart or bone/muscle problems that could make rehab unsafe
- You do not have a tracheostomy (a breathing tube through the neck)
- You do not have significant memory/thinking problems, active cancer, or an immunologic condition that could limit participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether noninvasive breathing support (like a mask or nasal prongs) can help people with Guillain-Barré syndrome who have trouble breathing. It aims to see if this approach can avoid the need for a breathing tube.
This study compares immunoadsorption (a blood-filtering treatment) versus intravenous immunoglobulin (IVIG) to see which works better and is safer for Guillain-Barré syndrome. It may help you by testing treatments commonly used to reduce nerve damage and improve recovery.
This trial compares two methods to help people with Guillain-Barre syndrome who are having trouble breathing on their own after being on a ventilator. It tests if adjusting the ventilator's sensitivity or doing specific breathing muscle exercises can improve blood oxygen levels and help them wean off the machine.
This study interviews children who had Guillain-Barré syndrome (GBS) to understand their experiences after recovery. It may help doctors better support young patients with GBS.
This study tests a high-tech rehab program using robots and advanced tools to help people recover from acute neuromuscular diseases. It aims to see if this approach improves leg strength and mobility better than standard care.
This trial tests a new medicine, tanruprubart (also called ANX005), for people with Guillain-Barré syndrome. It aims to see if the drug can help improve recovery when given soon after symptoms start.
Hear when a new Guillain Barré Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.